Lexicon Pharmaceuticals | LXRX - Trade Creditors


Lexicon Pharmaceuticals reported $3M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
Acadia Pharmaceuticals USD 44.57M 32.32M Jun/2026
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
Akebia Therapeutics USD 9.42M 1.04M Jun/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
BioMarin Pharmaceutical USD 913.67M 120.52M Jun/2026
Coherus Biosciences USD 13.17M 1.69M Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Halozyme Therapeutics USD 23.61M 9.51M Jun/2026
Illumina USD 230M 12M Jun/2026
Insmed USD 74.55M 1.18M Jun/2026
Ironwood Pharmaceuticals USD 3.24M 339K Mar/2026
J&J USD 9.22B 1.24B Jun/2026
Lexicon Pharmaceuticals USD 3M 87K Mar/2026
MacroGenics USD 3.44M 845K Jun/2026
MannKind USD 11.04M 5.1M Jun/2026
Merck USD 3.83B 36M Jun/2026
Moderna USD 167M 6M Jun/2026
Novartis USD 4.26B 64M Jun/2026
PTC Therapeutics USD 40.45M 14.96M Jun/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Thermo Fisher Scientific USD 3.34B 278M Mar/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
United Therapeutics USD 497.8M 500K Jun/2026
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024